Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs IBKR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Captures Overall Composite Edge (44.5 HOLD vs 48.5 HOLD), While IBKR Leads 4–2 on Growth & Valuation Pillars

NMR Overall Winner 6-Pillar Tally: NMR 2 – 4 IBKR Matrix Metrics: NMR 6 – 4 IBKR

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) captures the overall head-to-head institutional edge over Interactive Brokers Group, Inc. (IBKR) on higher Unified Composite conviction (44.5/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, R&D & Supply-Chain Moat), while IBKR wins 4–2 across the 6-pillar growth and valuation breakdown. NMR trades at $9.34 (12.7x Forward P/E, 25.1% operating margin) versus IBKR at $76.40 (23.7x Forward P/E, 77.6% operating margin).

  • Composite vs. Pillar Nuance: While IBKR currently prints a higher short-term Unified Composite Score (48.5/100 HOLD vs. NMR 44.5/100 HOLD), NMR captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 77.6% operating margin) and revenue trajectory (+17.9% vs. +13.5% YoY).
  • Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile IBKR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs IBKR
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
IBKR NASDAQ
Interactive Brokers Group, Inc. Class A Common Stock
Security Brokers, Dealers & Flotation Companies
$76.40
-2.59% 1D
Market Cap $139.4B
TTM Revenue $26.8B
Forward P/E 23.7x
Beta / 30D Vol 1.90β · 52% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 58.0 Fund 56.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 42
RSI-14: 41.7 · SMA20: $79.36 · SMA50: $84.53

6-Pillar Scorecard Institutional Category Breakdown (NMR 2 – 4 IBKR)

Columns: Metric · NMR · IBKR
1. Valuation Multiples NMR
Forward P/E 12.7x 23.7x
Trailing P/E 11.2x 31.2x
PEG Ratio 0.81x 1.16x
EV / Revenue 1.9x 4.4x
2. Growth & Scale IBKR
Revenue Growth (YoY) +17.9% +13.5%
Earnings Growth (YoY) +13.6% +16.9%
TTM Revenue (USD) $14.9B $26.8B
Market Cap $28.3B $139.4B
3. Profitability & Quality IBKR
Gross Margin 77.4% 92.7%
Operating Margin 25.1% 77.6%
Net Profit Margin 17.1% 16.7%
Return on Equity (ROE) 11.5% 23.7%
4. Balance Sheet & Cash Flow IBKR
Cash Generation (TTM) N/A $46.2B
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $22.4B Net Cash
Dividend Yield 3.34% 0.41%
5. Options & Positioning IBKR
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 30.7% (<1st %ile) 51.1% (54th %ile)
Put/Call OI Skew Thin ADR Chain 0.63x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) 15.1% of Rev ($4.04B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (6) vs IBKR (4)
Institutional Metric NMR IBKR Criterion Row Edge
Market Capitalization
Scale
$28.3B $139.4B Larger Scale IBKR
Trailing P/E Ratio
Valuation
11.2x 31.2x Lower Multiple NMR
Forward P/E Ratio
Valuation
12.7x 23.7x Lower Multiple NMR
Revenue Growth (YoY)
Growth
+17.9% +13.5% Higher Growth NMR
Operating Margin (TTM)
Profitability
25.1% 77.6% Higher Margin IBKR
Net Profit Margin
Profitability
17.1% 16.7% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
11.5% 23.7% Higher ROE IBKR
52-Week Range Position
Momentum
60% ($7–$11) 44% ($59–$99) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 1.90β · 52% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 48.5 / 100 (HOLD) Higher Composite IBKR
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $26.8B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 92.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 1.16x PEG · 4.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) $46.2B ($22.4B Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +8.44 pp
NMR: +2.36% · IBKR: -6.08%
3M Horizon NMR +13.78 pp
NMR: -1.84% · IBKR: -15.62%
6M Horizon NMR +25.14 pp
NMR: +16.69% · IBKR: -8.45%
1Y Horizon NMR +10.62 pp
NMR: +26.32% · IBKR: +15.7%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs IBKR. Trailing 12-month operating profitability (NMR 25.1% vs IBKR 77.6%) and valuation multiples (NMR 12.7x vs IBKR 23.7x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
IBKR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$26.8B
Gross Margin92.7%
Op. Margin77.6%
ROE / Fwd P/E23.7% · 23.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IBKR CONSOLIDATION
104d in phase · OBV ACCUMULATION
Current IV 51.1%
IV Percentile 54th %ile
Put/Call OI Skew 0.63x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact IBKR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $78.43 · IV 41.7%

IBKR Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($7,843)

Compare $7,843 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 41.7% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $80 / $85 Bull Call Spread

Buy 1x $80C · Sell 1x $85C · 32d

Net Entry $170 Debit
T+5d @ +5% Move +$82 (+49%)
Max Risk / Buffer $170 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $70 / $65 Bull Put Spread

Sell 1x $70P · Buy 1x $65P · 32d

Net Entry $82 Credit
Max Credit / Yield +$82 (+19.6% RoM)
Max Risk / Buffer -11.8% Cushion ($418 Mgn)
5d Edge & Liquidity 82% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq B

Dec 18 $70P / $80-$85C Seagull

Sell 1x $70P · Buy 1x $80/$85C · 32d

Net Entry $58 Debit
T+5d @ +5% Move +$158 (+17.6% RoM)
Max Risk / Buffer -10.7% Put Cushion ($896 Mgn)
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
IBKR Moat Profile High-Margin Pricing Power Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $139.4B market capitalization and 77.6% operating margin.
OpEx & R&D Reinvestment 15.1% of Rev ($4.04B)
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs IBKR Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) captures the overall head-to-head institutional edge over Interactive Brokers Group, Inc. (IBKR) on higher Unified Composite conviction (44.5/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, R&D & Supply-Chain Moat), while IBKR wins 4–2 across the 6-pillar growth and valuation breakdown. NMR trades at $9.34 (12.7x Forward P/E, 25.1% operating margin) versus IBKR at $76.40 (23.7x Forward P/E, 77.6% operating margin). Composite vs. Pillar Nuance: While IBKR currently prints a higher short-term Unified Composite Score (48.5/100 HOLD vs. NMR 44.5/100 HOLD), NMR captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 77.6% operating margin) and revenue trajectory (+17.9% vs. +13.5% YoY). Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile IBKR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IBKR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with IBKR at +13.5% YoY revenue growth and +16.9% YoY earnings growth on $26.8B TTM revenue (92.7% gross margin, 77.6% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $26.8B for IBKR. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 15.1% of Rev ($4.04B) (0 disclosures) for IBKR.

NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas IBKR trades at 23.7x Forward P/E, 31.2x Trailing P/E, 1.16x PEG, and 4.4x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus IBKR (23.7% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, IBKR carries 51.1% implied volatility (54th %ile, Balanced (25th–60th %ile)), a 0.63x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.90β · 52% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.